[CCI clinical practice guidelines: management of TIPS for portal hypertension (2019 edition)]

Zhonghua Gan Zang Bing Za Zhi. 2019 Aug 20;27(8):582-593. doi: 10.3760/cma.j.issn.1007-3418.2019.08.002.
[Article in Chinese]


Portal hypertension(PH) is one of the main complications of cirrhosis.Transjugular intrahepatic portosystemic shunt(TIPS) is the percutaneous creation of a conduit from the hepatic vein to the portal vein that is used to manage consequences of PH (i.e., variceal bleeding and refractory ascites) and used as a bridging therapy to liver transplant for decompensated cirrhosis. The following Clinical Practice Guidelines (CPGs) presents profession associational recommendations of the Chinese College of Interventionalists(CCI) on TIPS for PH. The CPGs was written by more than 30 experts in the field of TIPS in China (including interventional radiologists, liver surgeons, hepatologists and gastroenterologist, et al.). The panel of experts, produced these CPGs using evidence from PubMed and Cochrane database searches and combined with relevant expert consensuses and high quality clinical researches in China providing up to date guidance on TIPS for PH with the only purpose of improving clinical practice.


Keywords: Clinical practice guidelines; Liver cirrhosis; Portal hypertension; Refractory ascites; Transjugular intrahepatic portosystemic shunt; Variceal bleeding.

Publication types

  • Practice Guideline

MeSH terms

  • China
  • Esophageal and Gastric Varices / therapy
  • Gastrointestinal Hemorrhage / therapy
  • Humans
  • Hypertension, Portal / therapy*
  • Liver Cirrhosis / therapy
  • Portasystemic Shunt, Transjugular Intrahepatic*
  • Treatment Outcome